NEW YORK--(BUSINESS WIRE)--TransPerfect Life Sciences, a specialized division of TransPerfect, the world’s largest privately held provider of language and technology solutions for global business,
Newest Version of the Award-Winning Technology Enhances Security and Supports More Integrations
AGILITY CLINICAL CHOOSES TRANSPERFECT AS ETMF PROVIDER
E-Clinical Solution Enables Migration to a Paperless Global Trial Process
New Version of Award-Winning Platform Increases Transparency and Visibility
E-Clinical Solution Enables CTI to Move to a Paperless Global Trial Management Process
New Location to Serve Growing Demand for Integrated Language Services and Technology Solutions
Cubist selects Trial Interactive as their electronic Trial Master File (eTMF) enterprise solution across several clinical programs.
Award Recognizes Companies Who Demonstrate Leadership in Employing Technology to Advance Global Business.
TransPerfect Life Sciences to Transform Clinical Development for Biocom Members.
Trial Interactive Enables Regado Biosciences to Streamline 500-Site Global Study.
The implementation of best practices for clinical study and development conduct can streamline administrative burdens for investigator staff as well as study teams, and hopefully yield reduced costs in conducting global clinical development.
Aptalis Will Use Trial Interactive PSMF Solution to Meet New European Medicines Agency (EMA) Regulations.
TransPerfect's Trial Interactive Solution Enables Worldwide Clinical Trials to Streamline and Accelerate Global Study Management.